Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jee-Seon Kim

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Pharmaceutical Research|August 16, 2011
Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehiclesWon Ho Kong, Ki Hyun Bae, Sung Duk Jo, et al.
Biomaterials|January 9, 2013
Protein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumor-targeting of siRNAJee Seon Kim, Mi Hwa Oh, Jae Yoon Park, et al.
Psychoneuroendocrinology|October 5, 2016
Relationships between serum BDNF and the antidepressant effect of acute exercise in depressed womenJacob D Meyer, Kelli F Koltyn, Aaron J Stegner, et al.
Behavior Therapy|July 18, 2016
Influence of Exercise Intensity for Improving Depressed Mood in Depression: A Dose-Response StudyJacob D Meyer, Kelli F Koltyn, Aaron J Stegner, et al.
Medicine and Science in Sports and Exercise|July 7, 2017
Cognitive Resilience and Psychological Responses across a Collegiate Rowing SeasonMorgan R Shields, M Alison Brooks, Kelli F Koltyn, et al.
Biomaterials|August 26, 2011
Intracellular delivery of paclitaxel using oil-free, shell cross-linked HSA--multi-armed PEG nanocapsulesJeong Yu Lee, Ki Hyun Bae, Jee Seon Kim, et al.
Chemical Communications (Cambridge, England)|July 12, 2012
Thermally controlled wettability of a nanoporous membrane grafted with catechol-tethered poly(N-isopropylacrylamide)Jee Seon Kim, Taek Gyung Kim, Won Ho Kong, et al.
Substance Abuse Treatment, Prevention, and Policy|April 18, 2015
Implementing buprenorphine in addiction treatment: payer and provider perspectives in OhioTodd Molfenter, Carol Sherbeck, Mark Zehner, et al.
American Journal on Intellectual and Developmental Disabilities|June 23, 2010
Autism spectrum disorder in children and adolescents with fragile X syndrome: within-syndrome differences and age-related changesAndrea McDuffie, Leonard Abbeduto, Pamela Lewis, et al.
Journal of Addiction Medicine|November 28, 2017
Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in OhioTodd Molfenter, Carol Sherbeck, Sandy Starr, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Pharmaceutical Research|August 16, 2011
Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehiclesWon Ho Kong, Ki Hyun Bae, Sung Duk Jo, et al.
Biomaterials|January 9, 2013
Protein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumor-targeting of siRNAJee Seon Kim, Mi Hwa Oh, Jae Yoon Park, et al.
Psychoneuroendocrinology|October 5, 2016
Relationships between serum BDNF and the antidepressant effect of acute exercise in depressed womenJacob D Meyer, Kelli F Koltyn, Aaron J Stegner, et al.
Behavior Therapy|July 18, 2016
Influence of Exercise Intensity for Improving Depressed Mood in Depression: A Dose-Response StudyJacob D Meyer, Kelli F Koltyn, Aaron J Stegner, et al.
Medicine and Science in Sports and Exercise|July 7, 2017
Cognitive Resilience and Psychological Responses across a Collegiate Rowing SeasonMorgan R Shields, M Alison Brooks, Kelli F Koltyn, et al.
Biomaterials|August 26, 2011
Intracellular delivery of paclitaxel using oil-free, shell cross-linked HSA--multi-armed PEG nanocapsulesJeong Yu Lee, Ki Hyun Bae, Jee Seon Kim, et al.
Chemical Communications (Cambridge, England)|July 12, 2012
Thermally controlled wettability of a nanoporous membrane grafted with catechol-tethered poly(N-isopropylacrylamide)Jee Seon Kim, Taek Gyung Kim, Won Ho Kong, et al.
Substance Abuse Treatment, Prevention, and Policy|April 18, 2015
Implementing buprenorphine in addiction treatment: payer and provider perspectives in OhioTodd Molfenter, Carol Sherbeck, Mark Zehner, et al.
American Journal on Intellectual and Developmental Disabilities|June 23, 2010
Autism spectrum disorder in children and adolescents with fragile X syndrome: within-syndrome differences and age-related changesAndrea McDuffie, Leonard Abbeduto, Pamela Lewis, et al.
Journal of Addiction Medicine|November 28, 2017
Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in OhioTodd Molfenter, Carol Sherbeck, Sandy Starr, et al.
Pageof 7